Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF

ISIN DE000A2H9VJ3 · Ticker ETLI · LGIM Managers (Europe) Limited

The Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF. Ongoing charges are 0,49 % per year, the fund size is EUR 24 m. The distribution yield is 0,9 %.

Equity ETF · 100 % stocks
Cost p.a. 0,49 % ongoing charges
Fund size EUR 24 m converted to EUR
Distribution 0,9 % per provider data
Return 1 Y +25,5 % 3 Y p.a.: +3,5 %
Launched 2018since 2018-01-18
Exclusive to Finanzoo How good are the top 10 companies in this ETF?

The FScore rates each company from 0 to 100 on valuation, profitability, stability and dividend.

#Top 10 holdingWeightSectorFScore
1 Genmab A/S 4,4 % Healthcare 28,2
2 Xeris Pharmaceuticals Inc 3,1 % Healthcare
3 United Therapeutics Corporation 2,9 % Healthcare
4 Ligand Pharmaceuticals Incorporated 2,9 % Healthcare
5 Xencor Inc 2,9 % Healthcare
6 Halozyme Therapeutics Inc 2,8 % Healthcare
7 Biogen Inc 2,8 % Healthcare
8 AstraZeneca PLC 2,8 % Healthcare
9 Basilea Pharmaceutica AG 2,7 % Healthcare
10 Eisai Co. Ltd. 2,5 % Healthcare
Genmab A/S has an FScore of 28,2.How do the other top 10 companies score?
View all FScores – 7 days free

Composition

Regions

North America 69,1 %
Europe Developed 15,8 %
Japan 9,0 %
Asia Developed 2,6 %
Asia Emerging 2,3 %

Sectors

Fact sheet

Official name
Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF
Issuer
LGIM Managers (Europe) Limited
Domicile
–
Inception date
2018-01-18
Trading currency
EUR (Frankfurt Stock Exchange)
Ongoing charges
0,49 % p.a.
Fund size
EUR 24 m

Valuation & risk Premium

P/E (forward)
P/B
P/CF
Volatility 3 Y
Sharpe ratio 3 Y
Beta
Unlock P/E, P/B, volatility and Sharpe ratio →
Retirement portfolio

Planning your retirement portfolio? Find the right second building block.

The planned standard portfolio uses two ETFs from different risk classes. Our presets show suitable equity and bond ETFs.

Presets in the ETF screener →

Frequently asked questions about Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF

What are the costs of the Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF?
Ongoing charges are 0,49 % per year.
Does the Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF pay distributions?
According to provider data the distribution yield is 0,9 %.
How many holdings does the Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF have?
The number of holdings is not available.
Is the Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF suitable for a retirement portfolio?
That depends on your investment horizon and risk tolerance. Costs, diversification and the quality of the companies inside help with comparison. This is not investment advice.

Look inside every ETF – company by company.

FScore for 2.307 stocks and all ETFs, screener with all metrics, watchlist with FScore alerts and model portfolio.

Start free week → No credit card needed · No subscription after the free week

Data as of 2026-11-18. Returns in EUR; past performance is not an indicator of future results. Automated analysis, not investment advice. No guarantee for accuracy. All index and product names mentioned (e.g. MSCI®, S&P®, STOXX®, FTSE®) are trademarks of their respective owners and are used only to identify the ETF. Finanzoo is not affiliated with the index providers.